EU's Vaccine Export Blocks Weakened Brexit Agreement, Lawyers Say
Lawyers say EU officials’ now-scrapped decision to trigger a safeguard clause has cast a cloud over an agreement meant to prevent border checks between Ireland and Northern Ireland post-Brexit.
With mounting pressure on EU officials to ramp up vaccinations across the 27-member bloc, the European Commission took the drastic step last week of introducing export controls on vaccines made in EU factories.
In the same breath, the Commission also announced it would invoke an emergency measure in the Northern Ireland Protocol, the agreement that allows for the free flow of goods on the island of Ireland post-Brexit. The move was seen as a bid to ensure that British-Swedish firm AstraZeneca would not send unauthorized vaccine shipments to the U.K. through Northern Ireland.
This premium content is reserved for
Law.com International Subscribers.
BENEFITS OF A SUBSCRIPTION INCLUDE:
- Customized news by region including UK, Asia, Europe, Latin America, Middle East, Africa, and North America
- Cutting-edge research such as UK Top 100, China 45, and Asia 50
- Get the inside track on the biggest breaking stories that delve deep into the issues behind the headlines
- Comprehensive coverage of the dynamic legal market from people moves to the major international jurisdictions
- Global view into how legal tech, business of law, in-house and regulatory environments are intersecting worldwide
Already a subscriber? Sign In Now